title: Coping with the influenza vaccine shortage.
abstract: Faced with a shortage of the inactivated intramuscular influenza vaccine this year, the Centers for Disease Control and Prevention (CDC) has revised its guidelines for immunization and use of antiviral agents. The most rational solution at this time is to direct the supply of scarce vaccine to patients at highest risk of influenza-related complications.
authors.affiliation: Department of Infectious Diseases, The Cleveland Clinic Foundation, OH 44195, USA. mossads@ccf.org
authors.forename: Sherif B
authors.initials: SB
authors.lastname: Mossad
mesh_terms: D000368:Aged; D017028:Caregivers; D002487:Centers for Disease Control and Prevention, U.S.; D002908:Chronic Disease; D004345:Drug Industry; D017408:Guidelines as Topic; D006282:Health Personnel; D006801:Humans; D017589:Immunization Programs / Q000592:standards*; D007223:Infant; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000600:supply & distribution*; D007251:Influenza, Human / Q000517:prevention & control*; D037841:Pregnant People; D012307:Risk Factors; D014481:United States
chemical_list: D007252:Influenza Vaccines